Biom'Up

Biom’Up

Biom’Up®, a European-based medical device firm focused on collagen-based absorbable medical products for biosurgery, recently sought to obtain its first Class III Investigational Device Exemption (IDE) and Premarket Approval (PMA) in the United States.

Biom’Up, with the utilization of NAMSA’s APEX PROGRAM (formerly known as NAMSA’s MRO® Approach) methodology, achieved record-breaking results of $17M in cost savings and 23 months in accelerated timelines.

Biom’Up Achieves Record-Breaking Medical Device Development Timelines with NAMSA’s MRO® Approach

Watch this video on YouTube

Let’s Talk About Your Project

Ask a question or request a meeting with a NAMSA expert to discuss your specific project. We will follow up as quickly as possible. Also, please tell us how you heard about NAMSA.

First Name*

Last Name/Surname*

Business Email*

Company*

Where Are You Based?*

Location of Company Office You Work At/Report To*

How can we help?

By choosing to submit your information to contact NAMSA, you are providing NAMSA consent to process and store your information on the NAMSA Network. At any time, you can submit a request to withdraw your consent for the use of information provided by you. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.